Fear of Cancer Recurrence in Women with Gynecological Cancer: A Systematic Review
Abstract
Although some types of gynecological cancer have a poor prognosis and high recurrence rate, less is known about the fear of cancer recurrence (FCR) in gynecological cancer patients than in other cancer populations. Psychosocial problems may be experienced more in gender-specific cancers. In order to prevent future health problems related to FCR, it is critical to identify the factors affecting FCR in different subgroups and to develop various interventions. The aim of this study was to review the literature on the factors affecting the FCR in women diagnosed with gynecological cancer and interventions to reduce the FCR. The protocol of this review was registered with PROSPERO (Registration number: CRD42023452570). A total of 18 studies from 10 different countries were included in the systematic review by searching on the PubMed, ScienceDirect, Ovid, Sage, Scopus, Taylor & Francis, Web of Science, CINAHL Complete, and Cochrane databases were searched in English between July-August 2023 without year limitation to identify studies on FCR in women with gynecological cancer. Data from eligible articles were extracted and appraised for quality by two independent reviewers. In addition, bibliometric analysis method was used to visually map the studies on FCR in women with gynecological cancer according to the most frequently repeated keyword, number of citations, most cited author and publication year. The findings of the study are categorized and interpreted under two headings, “Interventions affecting FCR” and “Factors influencing FCR”. Sociodemographic characteristics such as age, economic status, social support, family history of cancer, psychological characteristics, quality of life and symptoms affect FCR. Deterioration in mental health and emotional weakness predict higher FCR, increase in positive emotional expression reduces FCR. The negative effects of cancer on sexuality and relationships, concerns about future treatments and emotional problems, and anxiety about not being able to fulfill their roles at home/work are the underlying reasons for the FCR. Therefore, professional psychosocial support should be provided to cancer survivors. Further studies are needed to identify the factors that trigger FCR and to plan interventions accordingly. This study is expected to encourage health professionals to plan interventions and research for gynecological cancer survivors.
References
2.La Rosa VL, Shah M, Kahramanoglu I, Cerentini TM, Ciebiera M, Lin LT, et al. Quality of life and fertility preservation counseling for women with gynecological cancer: an integrated psychological and clinical perspective. J Psychosom Obstet Gynecol. 2020;41(2):86–92. [Google Scholar] [PubMed]
3.Warren N, Melrose DM, Brooker JE, Burney S. Psychosocial distress in women diagnosed with gynecological cancer. J Health Psychol. 2018;23(7):893–904. [Google Scholar] [PubMed]
4.Niedzwiedz CL, Knifton L, Robb KA, Katikireddi SV, Smith DJ. Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority. BMC Cancer. 2019;19(1):1–8. [Google Scholar]
5.Zhang X, Sun D, Qin N, Liu M, Jiang N, Li X. Factors correlated with fear of cancer recurrence in cancer survivors: a meta-analysis. Cancer Nurs. 2022;45(5):406–15. [Google Scholar] [PubMed]
6.Mazzocco K, Masiero M, Carriero MC, Pravettoni G. The role of emotions in cancer patients’ decision-making. Ecancermedicalscience. 2019;13:914. [Google Scholar] [PubMed]
7.Mutsaers B, Butow P, Dinkel A, Humphris G, Maheu C, Ozakinci G, et al. Identifying the key characteristics of clinical fear of cancer recurrence: an international Delphi study. Psycho-Oncol. 2020;29(2):430–6. [Google Scholar]
8.Koral L, Cirak Y. The relationships between fear of cancer recurrence, spiritual well-being and psychological resilience in non-metastatic breast cancer survivors during the COVID-19 outbreak. Psycho-Oncol. 2021;30(10):1765–72. [Google Scholar]
9.Tauber NM, O’Toole MS, Dinkel A, Galica J, Humphris G, Lebel S, et al. Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis. J Clin Oncol. 2019;37(31):2899. [Google Scholar] [PubMed]
10.Anderson K, Smith A’, Diaz A, Shaw J, Butow P, Sharpe L, et al. A systematic review of fear of cancer recurrence among indigenous and minority peoples. Front Psychol. 2021;12:621850. [Google Scholar] [PubMed]
11.Luigjes-Huizer YL, Tauber NM, Humphris G, Kasparian NA, Lam WWT, Lebel S, et al. What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis. Psycho-Oncol. 2022;31:879–92. [Google Scholar]
12.Pang C, Humphris G. The relationship between fears of cancer recurrence and patient gender: a systematic review and meta-analysis. Front Psychol. 2021;12:640866. [Google Scholar] [PubMed]
13.Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300–22. [Google Scholar] [PubMed]
14.Ozga M, Aghajanian C, Myers-Virtue S, McDonnell G, Jhanwar S, Hichenberg S, et al. A systematic review of ovarian cancer and fear of recurrence. Palliat Support Care. 2015;13(6):1771–80. [Google Scholar] [PubMed]
15.Salani R. Survivorship planning in gynecologic cancer patients. Gynecol Oncol. 2013;130(2):389–97. [Google Scholar] [PubMed]
16.Myers SB, Manne SL, Kissane DW, Ozga M, Kashy DA, Rubin S, et al. Social-cognitive processes associated with fear of recurrence among women newly diagnosed with gynecological cancers. Gynecol Oncol. 2013;128(1):120–7. [Google Scholar] [PubMed]
17.Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Reprint—preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Physical Ther. 2009;89(9):873–80. [Google Scholar]
18.Centre for Reviews and Dissemination. Systematic reviews: CRD’s guidance for undertaking reviews in health care. In: Akers J, editor. Centre for reviews and dissemination. York, UK: University of York; 2013. [Google Scholar]
19.Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: systematic reviews of etiology and risk. In: Joanna Briggs institute reviewer’s manual. vol. 5. Adelaide, Australia: The Joanna Briggs Institute; 2020. p. 217–69. [Google Scholar]
20.Jeppesen M, Jensen P, Hansen D, Christensen R, Mogensen O. Patient-initiated follow up affects fear of recurrence and healthcare use: a randomised trial in early-stage endometrial cancer. BJOG: Int J Obstet Gynaecol. 2018;125(13):1705–14. [Google Scholar]
21.Manne SL, Virtue SM, Ozga M, Kashy D, Heckman C, Kissane D, et al. A comparison of two psychological interventions for newly diagnosed gynecological cancer patients. Gynecol Oncol. 2017;144(2):354–62. [Google Scholar] [PubMed]
22.Pradhan P, Sharpe L, Butow PN, Smith AB, Russell H. Is a brief online booklet sufficient to reduce fear of cancer recurrence or progression in women with ovarian cancer? Front Psychol. 2021;12:634136. [Google Scholar] [PubMed]
23.Hanprasertpong J, Geater A, Jiamset I, Padungkul L, Hirunkajonpan P, Songhong N. Fear of cancer recurrence and its predictors among cervical cancer survivors. J Gynecol Oncol. 2017;28(6):1–11. [Google Scholar]
24.Manne SL, Myers-Virtue S, Kissane D, Ozga ML, Kashy DA, Rubin SC, et al. Group-based trajectory modeling of fear of disease recurrence among women recently diagnosed with gynecological cancers. Psycho-Oncol. 2017;26(11):1799–809. [Google Scholar]
25.Sukyati I, Afiyanti Y, Rahmah H, Milanti A. Fear of recurrence predictors among Indonesian gynecological cancer survivors. J Int Dent Med Res. 2019;12(1):305–9. [Google Scholar]
26.Ayu NKP, Afiyanti Y. Fear of cancer recurrence and quality of life among gynaecological cancer survivors under treatment. Enfermería Clínica. 2021;31:S276–80. [Google Scholar]
27.Tsai LY, Lee SC, Wang KL, Tsay SL, Tsai JM. A correlation study of fear of cancer recurrence, illness representation, self-regulation, and quality of life among gynecologic cancer survivors in Taiwan. Taiwan J Obstet Gynecol. 2018;57(6):846–52. [Google Scholar] [PubMed]
28.Sam A. Fear of cancer recurrence in gynecologic cancer survivors: an overview. J Oncol Navig Surviv. 2018;9(3):1–10. [Google Scholar]
29.Tsai LY, Tsai JM, Tsay SL. Life experiences and disease trajectories in women coexisting with ovarian cancer. Taiwan J Obstet Gynecol. 2020;59(1):115–9. [Google Scholar] [PubMed]
30.Uner FO, Korukcu O. A qualitative exploration of fear of cancer recurrence in Turkish cancer survivors who were referred for colposcopy. Health Soc Care Commun. 2021;29(3):729–37. [Google Scholar]
31.Hamama-Raz Y, Shinan-Altman S, Levkovich I. The intrapersonal and interpersonal processes of fear of recurrence among cervical cancer survivors: a qualitative study. Support Care Cancer. 2022;30(3):2671–8. [Google Scholar] [PubMed]
32.Han PK, Gutheil C, Hutchinson RN, LaChance JA. Cause or effect? The role of prognostic uncertainty in the fear of cancer recurrence. Front Psychol. 2021;11:626038. [Google Scholar] [PubMed]
33.Ji J, Zhu H, Zhao JZ, Yang YQ, Xu XT, Qian KY. Negative emotions and their management in Chinese convalescent cervical cancer patients: a qualitative study. J Int Med Res. 2020;48(9):0300060520948758. [Google Scholar] [PubMed]
34.Galica J, Giroux J, Francis JA, Maheu C. Coping with fear of cancer recurrence among ovarian cancer survivors living in small urban and rural settings: a qualitative descriptive study. Eur J Oncol Nurs. 2020;44:101705. [Google Scholar] [PubMed]
35.Kyriacou J, Black A, Drummond N, Power J, Maheu C. Fear of cancer recurrence: a study of the experience of survivors of ovarian cancer. Canadian Oncol Nurs J. 2017;27(3):236. [Google Scholar]
36.Dewi SK, Afiyanti Y, Rachmawati IN. Fear of recurrence among gynaecological cancer survivors: a qualitative study. Enfermería Clínica. 2021;31:S352–5. [Google Scholar]
37.Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psycho-Oncol. 2013;22:978–86. [Google Scholar]
38.Krok-Schoen JL, Naughton MJ, Bernardo BM, Young GS, Paskett ED. Fear of recurrence among older breast, ovarian, endometrial, and colorectal cancer survivors: findings from the WHI LILAC study. Psycho-Oncol. 2018;27(7):1810–5. [Google Scholar]
39.Lebel S, Maheu C, Tomei C, Bernstein LJ, Courbasson C, Ferguson S, et al. Towards the validation of a new, blended theoretical model of fear of cancer recurrence. Psycho-Oncol. 2018;27(11):2594–601. [Google Scholar]
40.Maheu C, Lebel S, Bernstein LJ, Courbasson C, Singh M, Ferguson SE, et al. Fear of cancer recurrence therapy (FORTa randomized controlled trial. Health Psychol. 2023;42(3):182–94. [Google Scholar] [PubMed]
Copyright (c) 2024 The author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
